Chairperson: Scott MacDonnell, PhD, Regeneron

3:30 PM 

Mechanism of Action of Nerandomilast in Pulmonary Fibrosis
Carine Boustany, PhD, Boehringer Ingelheim 

3:55 PM 

Mechanosensing and NK Cell Immunotherapy: Converging Strategies to Reverse Fibrosis
David Lagares, PhD, MBA, Zenon Biotech

4:20 PM 

Locally Bioactivated PDE4 Inhibitor Prodrug for the Treatment of Fibrosetnotic Crohn’s Disease
Mitchell Jones, MD, PhD, Palisade Bio

4:45 PM

Closing Keynote Presentation: Fibrosis — From Mechanisms to Medicines
Thomas A Wynn, PhD, Pfizer